Search Results - "Grootens, Koen P"

On the use of positive test strategies when diagnosing mental disorders by van der Heijden, Paul T., Cefo, Irma, Witteman, Cilia L.M., Grootens, Koen P.

“…Despite the adverse impact diagnostic errors can have, clinical interviewing and decision-making in psychiatric practice have received relatively little…”
Get full text

Shared decision making in pharmacotherapy decisions, perceived by patients with bipolar disorder by Verwijmeren, Doris, Grootens, Koen P.

“…Background Shared decision making has been promoted as standard care, but there has been debate on the possible types. On the one hand, there is a more…”
Get full text

A shared decision journey to bridge the gap between treatment recommendation and low adherence? by Grootens, Koen P., Verwijmeren, Doris

Get full text

Shifting Perspectives on the Challenges of Shared Decision Making in Mental Health Care by Verwijmeren, Doris, Grootens, Koen P.

“…Although shared decision making (SDM) has become the most preferable way in doctor–patient communication, it is not fully implemented in mental health care…”
Get full text

Raloxifene augmentation in men and women with a schizophrenia spectrum disorder: A study protocol by Brand, Bodyl A., de Boer, Janna N., Oude Ophuis, Sebastianus B.J., Slot, Margot I.E., De Wilde, Bieke, Catthoor, Kirsten C.E.E.R., Goverde, Angelique J., Bakker, P. Roberto, Marcelis, Machteld C., Grootens, Koen P., Luykx, Jurjen J., Heringa, Sophie M., Weickert, Cynthia Shannon, Sommer, Iris E.C., Weickert, Thomas W.

“…Although acute psychotic symptoms are often reduced by antipsychotic treatment, many patients with schizophrenia are impaired in daily functioning due to the…”
Get full text

The perspectives of patients with lithium-induced end-stage renal disease by Kerckhoffs, Angèle P. M., Hartong, Erwin G. T. M., Grootens, Koen P.

“…Background Lithium is the treatment of choice for patients suffering from bipolar disorder (BD) but prolonged use induces renal dysfunction in at least 20% of…”
Get full text

Short term neurocognitive effects of treatment with ziprasidone and olanzapine in recent onset schizophrenia by van Veelen, Nicoletta M.J, Grootens, Koen. P, Peuskens, J, Sabbe, B.G.C, Salden, Miriam E, Verkes, R.J, Kahn, René S, Sitskoorn, Margriet M

“…Abstract Background Cognitive deficits are a core feature in schizophrenia. Cognitive deficits appear to be present at the onset of schizophrenia and persist…”
Get full text

The Direct and Long-Term Effects of Raloxifene as Adjunctive Treatment for Schizophrenia-Spectrum Disorders: A Double-Blind, Randomized Clinical Trial by Brand, Bodyl A, de Boer, Janna N, Marcelis, Machteld C, Grootens, Koen P, Luykx, Jurjen J, Sommer, Iris E

“…Abstract Background and hypothesis Several studies suggest that raloxifene, a selective estrogen receptor modulator, improves symptoms and cognition in…”
Get full text

Concurrent lithium and haemodialysis treatment: Clinical recommendations based on the literature and a multicentre survey by Kuiper, Wytse J., Grootens, Koen P., Kerckhoffs, Angèle P. M.

“…Introduction Lithium has an irreplaceable role in the treatment of severe mood disorders, but declining renal function associated with its use leads to…”
Get full text

Systematic review and practical guideline for the prevention and management of the renal side effects of lithium therapy by Schoot, Tessa S., Molmans, Thomas H.J., Grootens, Koen P., Kerckhoffs, Angèle P.M.

“…Lithium is the first line therapy of bipolar mood disorder. Lithium-induced nephrogenic diabetes insipidus (Li-NDI) and lithium nephropathy (Li-NP, i.e., renal…”
Get full text

Redesigning phase 3 and 4 trials to adopt shared decision making by Grootens, Koen P, Sommer, Iris E

Get full text

Simvastatin Augmentation for Patients With Early-Phase Schizophrenia-Spectrum Disorders: A Double-Blind, Randomized Placebo-Controlled Trial by Sommer, Iris E, Gangadin, Shiral S, de Witte, Lot D, Koops, Sanne, van Baal, C, Bahn, Sabine, Drexhage, Hemmo, van Haren, N E M, Veling, Wim, Bruggeman, R, Martens, Peter, Wiersma, Sybren, Veerman, Selene R T, Grootens, Koen P, van Beveren, Nico, Kahn, Rene S, Begemann, Marieke J H

“…Abstract Schizophrenia-spectrum disorders (SSD) are associated with increased inflammatory markers, both in brain and periphery. Augmentation with drugs that…”
Get full text

Weight changes associated with antiepileptic mood stabilizers in the treatment of bipolar disorder by Grootens, Koen P., Meijer, Anna, Hartong, Erwin G., Doornbos, Bennard, Bakker, P. Roberto, Al Hadithy, Asmar, Hoogerheide, Kirsten N., Overmeire, Frans, Marijnissen, Radboud M., Ruhe, Henricus G.

“…Objective To present up-to-date information and recommendations on the management of body weight changes during the use of antiepileptic mood stabilizers in…”
Get full text

Capillary blood sampling for the determination of clozapine concentrations: analytical validation and patient experience by Breken, Bianca D, Grootens, Koen P, Vermeulen Windsant-van den Tweel, Annemieke M, Hermens, Walter A, Derijks, Hieronymus J

“…Patients may be reluctant to start clozapine (CLZ) because of the frequent blood sampling needed for white blood cell monitoring, but also therapeutic drug…”
Get full text

Body weight gain in clozapine‐treated patients: Is norclozapine the culprit? by Jessurun, Naomi T., Derijks, Hieronymus J., Marum, Rob J., Jongkind, Amy, Giraud, Eline L., Puijenbroek, Eugène P., Grootens, Koen P.

“…The antipsychotic drug clozapine is associated with weight gain. The proposed mechanisms include blocking of serotonin (5‐HT2a/2c), dopamine (D2) and histamine…”
Get full text

Dispensability of Annual Laboratory Follow-Up After More than 2 Years of Valproic Acid Use: A Systematic Review by Meijboom, Rosanne W., Grootens, Koen P.

“…Background The necessity of annual laboratory follow-up in patients treated with valproic acid (VPA) is controversial. Objective We investigated the need for…”
Get full text

Oxybutynin for Antidepressant-Induced Hyperhidrosis by Grootens, Koen P.

“…Oxybutynin, an anticholinergic drug that is registered for urge incontinence, has shown to be effective in the treatment of excessive sweating in some cases…”
Get full text

A Case Report of Biotin Treatment for Valproate-Induced Hair Loss by Grootens, Koen P, Hartong, Erwin G T M

Get full text

Response to “Lithium therapy in patients with chronic kidney disease – a clinical dilemma?” by Schoot, Tessa S., Molmans, Thomas H.J., Grootens, Koen P., Kerckhoffs, Angèle P.M.

Get full text

Barriers and facilitators for systematically registering adverse drug reactions in electronic health records: a qualitative study with Dutch healthcare professionals by Geeven, Isa P A C, Jessurun, Naomi T, Wasylewicz, Arthur T M, Drent, Marjolein, Spuls, Phyllis I, Hoentjen, Frank, van Puijenbroek, Eugène P, Vonkeman, Harald E, Grootens, Koen P, van Doorn, Martijn B A, van Den Bemt, Bart J F, Bekker, Charlotte L

“…Systematically registering ADRs in electronic health records (EHRs) likely contribute to patient safety as it enables the exchange of drug safety data…”
Get more information